EGFR and neoplasm: Additional minor discrepancies, not affecting laboratory’s performance status, included the following: inability to detect the MET exon 14 skipping DNA variant in case 2 (identification only of MET(13)::MET(15) skipping reads in tumor RNA) and slight base calling differences in insertion/deletions in EGFR and MET for cases 1 and 2.